Mylan launches generic Fenoglide

PITTSBURGH — Mylan on Wednesday announced the launch of its generic og Fenoglide (fenofibrate) tablets. The drug is indicated to treat high LDL cholesterol, total cholesterol, triglycerides and apolipoprotein B as an adjunct to diet in adults with hypercholesterolemia or mixed dyslipidemia. 

 

Mylan’s fenofibrate tablets will be available in 40- and 120-mg dosage strengths. The product had a total of $28.6 million for the 12 months ended April 30, according to IMS Health.